EMA — authorised 2 December 2015
- Marketing authorisation holder: GlaxoSmithKline Trading Services
- Status: approved
🇪🇺 Nucala in European Union
EMA authorised Nucala on 2 December 2015
Marketing authorisation
Nucala in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in European Union
Frequently asked questions
Is Nucala approved in European Union?
Yes. EMA authorised it on 2 December 2015.
Who is the marketing authorisation holder for Nucala in European Union?
GlaxoSmithKline Trading Services holds the EU marketing authorisation.